acmefirewoodis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
World Conference on Rare Diseases
Sometimes success is just a matter of being in the right place at the right time with the right product.
Gerald has and will continue to assemble a team of top notch individuals to take advantage of the opportunities ahead.
So much potential for under a dime.
Section 216: Good news for Amarantus:
https://www.govtrack.us/congress/bills/113/hr4302/text
If someone is stupid enough to sell shares under .08 be smart enough to buy a few.
Expecting more news soon.
Have a great day!!!
Twitter: @AmarantusBio ....9,807 followers
End of day dump ahead? $3.40 close?
.85 or $6.00 on April 2.
Gerald is making "all the right moves". It's only a matter of time before the market recognizes it.
"Patience is a virtue."
Best of luck to all.
p.s. CNN needs to highlight LymPro.
Launching the first blood test to detect Alzheimer's will be major news.
Up trend has started.
Good luck to all.
Thought this link might prove useful in the future:
http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/21/viewFullReport
I think it's only a matter of time before you see Gerald being interviewed by 60 Minutes, DateLine, CNN, or Forbes. Not if but when.
I asked Gerald about this possibility about six months ago and he stated "when the time is right" during one of my fourteen conversations with him that supposebly didn't actually happen.
The basket will be removed from covering the "LymPro" light soon enough. Be patient.
Don't regret not owning more shares when it happens.
Looking forward to tomorrow morning. Christmas in March?
50% jump on Monday?
.125 range or higher?
It would still be only 50% of Napadano's price target of .24.
Let's see what surprises Gerald has for the shorts on Monday.
Word is getting out about LymPro.
Must read if you haven't read them yet:
The Life Sciences Report – “From Lab Bench to Bedside: David Lowe Brings Common Sense to Neuroscience Investing”
http://www.thelifesciencesreport.com/pub/na/from-lab-bench-to-bedside-david-lowe-brings-common-sense-to-neuroscience-investing
How Alzheimer’s Blood Test Could Paradoxically Change the Long-Term Care Market
http://seekingalpha.com/article/2114603-how-alzheimers-blood-tests-could-paradoxically-free-the-long-term-care-market
Here you go:
Interesting week ahead. Reasonable potential catalysts could take it back to the .15 range by Friday.
I'm still waiting to wake-up one morning and turn on CNN and find Gerald being interviewed about LymPro.
p.s. I hope you didn't sell yesterday.
Along with the "tweet" from Gerald these are two more reasons the share price recovered on Friday:
The Life Sciences Report – “From Lab Bench to Bedside: David Lowe Brings Common Sense to Neuroscience Investing”
http://www.thelifesciencesreport.com/pub/na/from-lab-bench-to-bedside-david-lowe-brings-common-sense-to-neuroscience-investing
How Alzheimer’s Blood Test Could Paradoxically Change the Long-Term Care Market
http://seekingalpha.com/article/2114603-how-alzheimers-blood-tests-could-paradoxically-free-the-long-term-care-market
I previously posted that there are many individual on the board who don't know how to read for comprehension.
Who said I had only 112,000 shares?
p.s. It's so unfair of me to poke and prod certain individuals.
Since you're obviously an expert on Twitter. Please provide me with a list of all the names that I use there "posting nonsense over and over again in different ways".
Looking forward to the list.
p.s. I now own more than 112,000 shares of $AMBS so I guess that's good for you.
How can I "spam" social media when I had 60 followers on twitter at that time. Amarantus had over 9,600.
If you really think I can impact the share price by posting on Twitter I think you are out of touch with reality.
Best of luck to you. I hope $AMBS goes to .50 or higher this year.
p.s. Since then I'm adding more followers than I ever thought possible. I'm up to 70 now.
The problem is that even if Afrezza is approved that Mannkind's market cap is still excessive if REMS are placed on Afrezza and a cancer warning is placed on the label as it was with Exubera.
Arena, Amarin, and Vivus all lost a substantial portion of their market cap after their "blockbuster" drugs were approved.
Gerald told me that the plan to up-list was "on track". He also had previously "tweeted" that he had no intention of doing a reverse split to up-list with the share price so low.
With that being the case then it is obvious that he expects several catalysts that will move the share price substantially higher. Who better to know than Gerald?
I expect next week that he will layout the plan for the next six months.
"Doc" says a partnership is in the works. Interesting times ahead.
Best of luck to all.
Thanks for the update. Current share price is a gift.
That will be very evident next week.
p.s. Imagine what partnership news would do to the share price.
Just one comment about the current share price: "Recognize a gift when you see it."
Buy at the open tomorrow.
Interesting days ahead.
Just trying to make the board a bit more interesting.
I just finished reading this:
http://www.thelifesciencesreport.com/pub/na/from-lab-bench-to-bedside-david-lowe-brings-common-sense-to-neuroscience-investing
I think God is pretty much irrelevant when it come to the stock market in general.
Promises, promises.
I can only hope for .05 shares tomorrow or Monday.
It may not be below .10 next Friday.
Thought .067 would be the bottom.
Adding another 100,000 shares tomorrow.
Best of luck to everyone.
p.s. Someone dumped 2,000,000 shares in the last twenty minutes of trading. They definitely want to try to buy cheaper shares. Let's hope Gerald puts a "kink" in their plans soon.
Anyone who follows penny stocks especially those with tremendous potential realize that the share price could double or triple at any time with news that was completely unexpected: i.e. partnership with a Chinese drug company or a substantial grant from a major health organization.
This is what makes owning $AMBS shares so exciting. The tremendous number of realistic but unknown catalysts going forward that can be announced at any time.
Good luck to all the shareholders.
p.s. .07 is a great price to add shares.
All IMHO.
Don't bet against Gerald succeeding. Especially at .07.
Risk/reward makes buying/adding shares here a "no brainer".
Just saying!!!
p.s. Only a few days until the end of the quarter.
My "saying" is when it comes to buying at the bottom most individuals will miss doing so. Others will come close but then regret not having bought more shares as the share price moves higher.
I'll add another 100,000 shares today and another 100,000 shares tomorrow.
I'm not expecting to buy at the bottom just hoping to get close.
Good luck to you.
What you do or say has no impact on what I do just as what I do or say shouldn't influence anyone's investing decision.
p.s. After speaking with Gerald yesterday I firmly believe that anyone buying here will be substantially rewarded and that anyone selling here will regret it very soon. IMHO.
I suggest you buy before the next press release.
Especially before "your day" next week.
Just saying!!!
I spoke with Gerald this afternoon for about twenty minutes.
I'll summarize by saying that everything that Gerald has stated to expect is "on track" to include the commercialization of LymPro and the up-listing.
He also stated that "the company is in the best shape its ever been".
Obviously he has no control over the day to day fluctuations in the share price.
It's interesting to note that he tweeted this afternoon:
Gerald Commissiong ?@G_Commish 5h
@TalkaboutBio You only lose if you sell. If so, that is your decision. My job is to build a world class company. And that is what I am doing
I wasn't going to post again until after the up-listing but there have been so many negative posts by individuals wanting a cheaper share price to re-buy or add shares I thought I'd try to bring some positive vibes to the board.
"Patience is a virtue."
Good luck to all.
My advice: If you own shares hold on to them. If you can afford to add shares at the current price do so.
p.s. I forgot to ask him about Stanford's chances in the NCAA tournament.
Some entity is definitely accumulating shares here. Walking it up slowly so as to try not to spike the price.
Remember what happened to ACAD last year. Let's hope this is a similar situation.
I still think the company will be either bought by a big pharma company or announce a development partnership within the next three months. $15.00 is realistic within six months. $150M market cap.
Enjoy the ride as the accumulation continues.
This will be my last post on the board until after AMBS uplists if it happens.
Good luck to everyone. I hope all of you make a lot of money.
It's not a matter of switching. It's a matter of when is it time to buy a stock and when is it time not to.
After Gerald put his foot in his mouth and said there would be no near term partnership on LymPro that was a good time not to buy considering there were expectations that a partnership was in the works.
Now that we have clarification on the LPC financing agreement I would say now is a time to buy.
Obviously I have no control over which direction the share price goes. I just try to assess current information and act accordingly.
As far as I know everyone here can exercise free will and do as they choose.
Best of luck to everyone.
Gerald will have approximately $32,500,000 in cash from the conversion of the warrants at .06, the debentures at .04, the "new" warrants at .12, and the sell of shares to Lincoln Park Capital.
Add to that the possibility of grant funding or upfront cash for a LymPro partnership or a development partnership for an orphan indication for MANF and you're talking real money.
Interesting weeks ahead.
Just saying!!!
p.s. I don't see any reason why AMBS couldn't be trading on the NASDAQ before the end of the second quarter.
If Gerald were to release positive LymPro news before the open tomorrow I think this could close above .12.
http://finance.yahoo.com/echarts?s=AMBS+Interactive#symbol=ambs;range=ytd;compare=;indicator=volume;charttype=area;crosshair=on;ohlcvalues=0;logscale=off;source=;
Just saying!!!
I'm thinking this might see above a dime tomorrow.
Guess I'll buy a few shares at the open.
"Situational approach" to investing says that when the situation changes then an investor should act accordingly.
It happens.
p.s. The terms of the agreement are much better than I expected.
Add in the shares from the conversion of the warrants, conversion of the debentures, shares given to LPC, shares used to acquire eltoprazine, and the number of shares is in excess of 800,000,000. Assuming LPC acquires shares at an average of .10/shares that's all one billion shares "in play" now.
Unless I overlooked something the best thing about the agreement is that LPC doesn't buy shares at a discount to the market price. That surprised me.
Just saying!!!
p.s. If the LymPro news is good I may buy a few shares when it is announced.
It appears I'm wrong.
Not the first time.
Back above $20.00 by the close tomorrow.
Something to consider:
"Commerzbank’s commodity strategists, for their part, attempt to caution goldbugs that the fervor could be temporary:
"The rise in the gold price is likely once again to have been driven by speculation to a major extent, however, and is thus unlikely to continue unchecked. At present, physical gold buyers appear to be exercising restraint, as evidenced by the sluggish coin sales that have been seen for several weeks now in the US. What is more, gold in China is trading at a discount to world market prices. At the beginning of the week, the China Gold Association had already pointed out that domestic gold demand in the first quarter of 2014 could decline by 17% year-on-year to 250 tons."